Discontinued — last reported Q4 '25
Roivant Sciences Total investment securities decreased by 6.0% to $407.99M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.7%, from $302.94M to $407.99M. Over 5 years (FY 2020 to FY 2025), Total investment securities shows an upward trend with a 16.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests capital growth or reinvestment of premiums, while a decrease may indicate asset liquidation to cover claims or market value depreciation.
This represents the aggregate fair value of an insurance company's portfolio of debt and equity securities held for inve...
Peers typically maintain a high ratio of investment securities to total assets to ensure liquidity for claims.
fin_total_investment_securities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $180.36M | $436.78M | $398.74M | $325.83M | $301.29M | $246.61M | $272.47M | $304.32M | $296.24M | $250.39M | $239.93M | $247.75M | $262.98M | $311.35M | $290.04M | $302.94M | $283.81M | $412.32M | $433.91M | $407.99M |
| QoQ Change | — | +142.2% | -8.7% | -18.3% | -7.5% | -18.1% | +10.5% | +11.7% | -2.7% | -15.5% | -4.2% | +3.3% | +6.1% | +18.4% | -6.8% | +4.4% | -6.3% | +45.3% | +5.2% | -6.0% |
| YoY Change | — | — | — | — | +67.0% | -43.5% | -31.7% | -6.6% | -1.7% | +1.5% | -11.9% | -18.6% | -11.2% | +24.3% | +20.9% | +22.3% | +7.9% | +32.4% | +49.6% | +34.7% |